Atrial Fibrillation Clinical Trials in Riga
2 recruitingRiga, Latvia
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Anthos Therapeutics, Inc.1,900 enrolled721 locationsNCT05712200
Recruiting
Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
Atrial FibrillationSyncopeBradycardia+2 more
Biotronik SE & Co. KG1,400 enrolled31 locationsNCT04075084